Skip to content
healthcare.dev

buprenorphine hydrochloride and naloxone hydrochloride dihydrate

NDC 51407-948, buprenorphine hydrochloride and naloxone hydrochloride dihydrate, tablet, from Golden State Medical Supply, Inc..

Product NDC
51407-948
Status
Listed
Labeler
Golden State Medical Supply, Inc.
Dosage form
TABLET
Route
SUBLINGUAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203326
DEA schedule
CIII
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51407-948 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPRENORPHINE HYDROCHLORIDE2 mg/1
  • NALOXONE HYDROCHLORIDE DIHYDRATE.5 mg/1

Pharmacologic classes

Opioid Antagonist [EPC]; Opioid Antagonists [MoA]; Partial Opioid Agonist [EPC]; Partial Opioid Agonists [MoA]

Package NDCNDC-11Package
51407-948-305140709483030 TABLET in 1 BOTTLE (51407-948-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4f6e0056-b19d-0d0e-e063-6294a90a16e5

Use it

Look up 51407-948 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51407-948 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51407-948. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.